Search Results - "Fogaca, Manoela V."
-
1
Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Published in Frontiers in cellular neuroscience (12-03-2019)“…Major depressive disorder (MDD) is a debilitating illness characterized by neuroanatomical and functional alterations in limbic structures, notably the…”
Get full text
Journal Article -
2
Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses
Published in Neuropsychopharmacology (New York, N.Y.) (11-10-2024)“…Major depressive disorder (MDD) is associated with disruptions in glutamatergic and GABAergic activity in the medial prefrontal cortex (mPFC), leading to…”
Get full text
Journal Article -
3
Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents
Published in Neurobiology of disease (01-02-2020)“…Dysfunction of medial prefrontal cortex (mPFC) in association with imbalance of inhibitory and excitatory neurotransmission has been implicated in depression…”
Get full text
Journal Article -
4
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
Published in PloS one (14-07-2016)“…Cannabidiol (CBD) is a major Cannabis sativa constituent, which does not cause the typical marijuana psychoactivity. However, it has been shown to be active in…”
Get full text
Journal Article -
5
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Published in Molecular psychiatry (01-12-2019)“…Efforts to develop efficacious antidepressant agents with novel mechanisms have been largely unsuccessful since the 1950’s until the discovery of ketamine, an…”
Get full text
Journal Article -
6
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
Published in Proceedings of the National Academy of Sciences - PNAS (02-01-2019)“…Ketamine, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, produces rapid and long-lasting antidepressant effects in major depressive disorder…”
Get full text
Journal Article -
7
Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses
Published in Molecular psychiatry (01-07-2021)“…Major depressive disorder (MDD) is associated with alterations of GABAergic interneurons, notably somatostatin (Sst) as well as parvalbumin (Pvalb), in…”
Get full text
Journal Article -
8
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
Published in Neuropharmacology (01-06-2018)“…Repeated injections of cannabidiol (CBD), the major non-psychotomimetic compound present in the Cannabis sativa plant, attenuate the anxiogenic effects induced…”
Get full text
Journal Article -
9
Cannabidiol, neuroprotection and neuropsychiatric disorders
Published in Pharmacological research (01-10-2016)“…[Display omitted] Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis sativa. It has possible therapeutic effects over a broad…”
Get full text
Journal Article -
10
N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects
Published in Neuropsychopharmacology (New York, N.Y.) (01-12-2019)“…Currently available antidepressants have a delayed onset and limited efficacy, highlighting the need for new, rapid and more efficacious agents. Ketamine, an…”
Get full text
Journal Article -
11
Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation
Published in Neuropsychopharmacology (New York, N.Y.) (01-09-2020)“…We previously reported that the serotonergic system is important for the antidepressant-like effects of ketamine, a non-competitive N-methyl-D-aspartate…”
Get full text
Journal Article -
12
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
Published in The international journal of neuropsychopharmacology (01-07-2013)“…Cannabidiol (CBD), the main non-psychotomimetic component of the plant Cannabis sativa, exerts therapeutically promising effects on human mental health such as…”
Get full text
Journal Article -
13
Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
Published in Molecular neurobiology (01-02-2019)“…Currently available antidepressants have a substantial time lag to induce therapeutic response and a relatively low efficacy. The development of drugs that…”
Get full text
Journal Article -
14
Animal models of anxiety disorders and stress
Published in Revista brasileira de psiquiatria (2013)“…Anxiety and stress-related disorders are severe psychiatric conditions that affect performance in daily tasks and represent a high cost to public health. The…”
Get full text
Journal Article -
15
Prefrontal cortex interneurons display dynamic sex-specific stress-induced transcriptomes
Published in Translational psychiatry (11-11-2019)“…γ-aminobutyric acid (GABA) inhibitory interneurons play a key role in efferent and afferent control of principle neuron activity in the prefrontal cortex…”
Get full text
Journal Article -
16
M1 acetylcholine receptors in somatostatin interneurons contribute to GABAergic and glutamatergic plasticity in the mPFC and antidepressant-like responses
Published in Neuropsychopharmacology (New York, N.Y.) (01-08-2023)“…Alterations in glutamatergic and GABAergic function in the medial prefrontal cortex (mPFC) are prevalent in individuals with major depressive disorder,…”
Get full text
Journal Article -
17
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Published in Frontiers in pharmacology (23-05-2017)“…Beneficial effects of cannabidiol (CBD) have been described for a wide range of psychiatric disorders, including anxiety, psychosis, and depression. The…”
Get full text
Journal Article -
18
The synergistic mechanism of action of Dajianzhong decoction in conjunction with ketamine in the treatment of depression
Published in Biomedicine & pharmacotherapy (01-09-2023)“…Depression is a multifactorial syndrome with a variety of underlying pathological mechanisms. While ketamine, an N-methyl-D-aspartate receptor (NMDAR)…”
Get full text
Journal Article -
19
The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior
Published in Neuropharmacology (01-08-2012)“…Cannabinoid receptor 1 (CB1) agonists usually induce dose-dependent biphasic effects on anxiety-related responses. Low doses induce anxiolytic-like effects,…”
Get full text
Journal Article -
20
The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors
Published in Behavioural brain research (15-10-2015)“…•AEA induces biphasic effects in the modulation of anxiety-like behaviors in the dlPAG.•AEA induces an anxiolytic-like effect in the dlPAG at lower doses.•The…”
Get full text
Journal Article